Qi Long Lu
29Patents
3h-index
35Co-inventors
63Inventor score
Filing activity: Jun 26, 1997 → Jun 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9078911B2 | Antisense oligonucleotides | Chemistry; Metallurgy | 62 | Active |
| US5985237A | Process for producing lithium manganese oxide suitable for use as cathode material of lithium ion secondary batteries | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6348182B1 | Process for producing lithium manganese oxide with spinel structure | Emerging Cross-Sectional Technologies | 11 | Expired |
| US10434113B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 3 | Active |
| US10456367B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 3 | Active |
| US10245235B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 3 | Active |
| US10434072B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 3 | Active |
| US11931371B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 2 | Active |
| US10993954B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 2 | Active |
| US10561623B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 2 | Active |
| US10751298B2 | Compositions and methods for treating muscular dystrophy and other disorders | Human Necessities | 2 | Active |
| US9333215B2 | Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10307492B2 | Modified MGLUR6 promoter and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9023890B2 | Nitrate esters and their use for the treatment of muscle and muscle related diseases | Chemistry; Metallurgy | 0 | Active |
| US8487090B2 | Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12252463B2 | Compositions and methods of making ribitol | Chemistry; Metallurgy | 0 | Active |
| US9713623B2 | Triazine cationic polymers and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10238676B2 | Application of ginsenoside RG3 in preparing medicine for preventing and/or treating dementia, and medicine for treating dementia | Human Necessities | 0 | Active |
| US10350305B2 | Compositions for treating dystroglycanopathy disorders | Chemistry; Metallurgy | 0 | Active |
| US9994961B2 | Electrocatalyst for hydrogen evolution and oxidation reactions | Emerging Cross-Sectional Technologies | 0 | Active |
| US10172812B2 | Compounds and methods for treating muscular dystrophy and other disorders | Human Necessities | 0 | Active |
| US8569251B2 | Use of microwave irradiation for delivery of macromolecules | Chemistry; Metallurgy | 0 | Active |
| US11639516B2 | Hydroxytyrosol sturgeon skin gelatin film with antioxidant activity and Salmonella detection ability and a method of preparing the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US12234267B2 | Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof | Human Necessities | 0 | Active |
| US9050373B2 | Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.